Medtronic plc (MDT) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Medtronic plc (MDT) Bundle
Discover the true value of Medtronic plc (MDT) with our professional-grade DCF Calculator! Adjust essential assumptions, explore various scenarios, and evaluate how changes affect Medtronic plc (MDT) valuation – all within a single Excel template.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 28,913.0 | 30,117.0 | 31,686.0 | 31,227.0 | 32,364.0 | 33,299.8 | 34,262.7 | 35,253.5 | 36,272.9 | 37,321.7 |
Revenue Growth, % | 0 | 4.16 | 5.21 | -1.45 | 3.64 | 2.89 | 2.89 | 2.89 | 2.89 | 2.89 |
EBITDA | 7,825.0 | 8,192.0 | 9,554.0 | 8,475.0 | 8,203.0 | 9,117.7 | 9,381.3 | 9,652.6 | 9,931.7 | 10,218.9 |
EBITDA, % | 27.06 | 27.2 | 30.15 | 27.14 | 25.35 | 27.38 | 27.38 | 27.38 | 27.38 | 27.38 |
Depreciation | 2,663.0 | 2,702.0 | 2,707.0 | 2,697.0 | 2,647.0 | 2,899.8 | 2,983.7 | 3,069.9 | 3,158.7 | 3,250.0 |
Depreciation, % | 9.21 | 8.97 | 8.54 | 8.64 | 8.18 | 8.71 | 8.71 | 8.71 | 8.71 | 8.71 |
EBIT | 5,162.0 | 5,490.0 | 6,847.0 | 5,778.0 | 5,556.0 | 6,217.9 | 6,397.7 | 6,582.7 | 6,773.0 | 6,968.8 |
EBIT, % | 17.85 | 18.23 | 21.61 | 18.5 | 17.17 | 18.67 | 18.67 | 18.67 | 18.67 | 18.67 |
Total Cash | 10,948.0 | 10,817.0 | 10,573.0 | 7,959.0 | 8,005.0 | 10,480.9 | 10,784.0 | 11,095.8 | 11,416.7 | 11,746.8 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 4,645.0 | 5,462.0 | 5,551.0 | 5,998.0 | 6,128.0 | 5,984.8 | 6,157.9 | 6,335.9 | 6,519.1 | 6,707.6 |
Account Receivables, % | 16.07 | 18.14 | 17.52 | 19.21 | 18.93 | 17.97 | 17.97 | 17.97 | 17.97 | 17.97 |
Inventories | 4,229.0 | 4,313.0 | 4,616.0 | 5,293.0 | 5,217.0 | 5,100.6 | 5,248.0 | 5,399.8 | 5,555.9 | 5,716.6 |
Inventories, % | 14.63 | 14.32 | 14.57 | 16.95 | 16.12 | 15.32 | 15.32 | 15.32 | 15.32 | 15.32 |
Accounts Payable | 1,996.0 | 2,106.0 | 2,276.0 | 2,662.0 | 2,410.0 | 2,467.5 | 2,538.9 | 2,612.3 | 2,687.8 | 2,765.6 |
Accounts Payable, % | 6.9 | 6.99 | 7.18 | 8.52 | 7.45 | 7.41 | 7.41 | 7.41 | 7.41 | 7.41 |
Capital Expenditure | -1,213.0 | -1,355.0 | -1,368.0 | -1,459.0 | -1,587.0 | -1,504.3 | -1,547.8 | -1,592.6 | -1,638.6 | -1,686.0 |
Capital Expenditure, % | -4.2 | -4.5 | -4.32 | -4.67 | -4.9 | -4.52 | -4.52 | -4.52 | -4.52 | -4.52 |
Tax Rate, % | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
EBITAT | 6,096.4 | 5,082.7 | 6,253.8 | 4,048.0 | 4,222.4 | 5,347.0 | 5,501.6 | 5,660.7 | 5,824.4 | 5,992.8 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | 668.4 | 5,638.7 | 7,370.8 | 4,548.0 | 4,976.4 | 7,059.7 | 6,688.3 | 6,881.7 | 7,080.7 | 7,285.4 |
WACC, % | 7.69 | 7.63 | 7.62 | 7.43 | 7.48 | 7.57 | 7.57 | 7.57 | 7.57 | 7.57 |
PV UFCF | ||||||||||
SUM PV UFCF | 28,219.1 | |||||||||
Long Term Growth Rate, % | 4.00 | |||||||||
Free cash flow (T + 1) | 7,577 | |||||||||
Terminal Value | 212,316 | |||||||||
Present Terminal Value | 147,419 | |||||||||
Enterprise Value | 175,638 | |||||||||
Net Debt | 24,763 | |||||||||
Equity Value | 150,875 | |||||||||
Diluted Shares Outstanding, MM | 1,330 | |||||||||
Equity Value Per Share | 113.42 |
What You Will Get
- Comprehensive MDT Financials: Access both historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Real-Time Calculations: Intrinsic value and NPV are computed automatically.
- Scenario Analysis: Explore various scenarios to assess Medtronic’s future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- 🔍 Real-Life MDT Financials: Pre-filled historical and projected data for Medtronic plc (MDT).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Medtronic’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Medtronic’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download: Get the pre-built Excel file containing Medtronic's financial data.
- Customize: Modify forecasts such as revenue growth, EBITDA %, and WACC to fit your analysis.
- Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various projections and quickly compare different outcomes.
- Make Decisions: Leverage the valuation results to inform your investment approach.
Why Choose Medtronic plc (MDT)?
- Innovative Solutions: Cutting-edge medical technologies that enhance patient care.
- Global Reach: Operates in over 150 countries, ensuring accessibility to healthcare solutions.
- Commitment to Quality: Rigorous standards and testing processes guarantee product reliability.
- Patient-Centric Approach: Focused on improving outcomes and quality of life for patients.
- Industry Leader: Recognized for excellence and trusted by healthcare professionals worldwide.
Who Should Use This Product?
- Investors: Accurately estimate Medtronic plc’s (MDT) fair value before making investment decisions.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis of Medtronic plc (MDT).
- Consultants: Quickly adapt the template for valuation reports tailored to clients interested in Medtronic plc (MDT).
- Entrepreneurs: Gain insights into financial modeling practices employed by industry leaders like Medtronic plc (MDT).
- Educators: Use it as a teaching tool to illustrate valuation methodologies relevant to Medtronic plc (MDT).
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Medtronic plc (MDT) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Medtronic plc (MDT).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.